Oral administration of a live-attenuated Bordetella bronchiseptica vaccine (Vanguard B Oral) induces protective immunity against challenge 7 days after vaccination in dogs.

Vanguard B Oral provides significant protective immunity against Bordetella bronchiseptica as early as 7 days post-vaccination.

This randomized, blinded, controlled study evaluated the onset of immunity following a single oral dose of a live-attenuated Bordetella bronchiseptica (Bb) vaccine (Vanguard B Oral) in 8-week-old Beagle puppies. Forty puppies were equally divided into vaccinate and placebo control groups, with aerosol challenge using virulent Bb administered 7 days post-vaccination. The primary efficacy endpoint was coughing on 2 consecutive days, a criterion met by 85% of controls versus only 20% of vaccinates, representing a significant reduction in disease expression. Vaccinated dogs also demonstrated markedly fewer coughing observation periods (3.2% vs 15.8%), shorter mean coughing duration (2.4 days vs 5.5 days), and significantly lower total clinical scores (median 15.0 vs 27.0). Importantly, the difference in clinical scores remained significant even after excluding ocular and nasal discharge, suggesting that the vaccine's protective effect extended beyond mucosal secretion suppression. Microplate agglutination titers were measured at multiple timepoints to assess serological response. The vaccine demonstrated a favorable safety profile, with only sporadic mild clinical signs observed in vaccinates. This study provides clinically relevant evidence that Vanguard B Oral can induce protective immunity within 7 days of a single oral administration, which has meaningful implications for shelter medicine, boarding facilities, and outbreak scenarios where rapid protection is critical. The oral delivery route also offers practical advantages in terms of ease of administration and reduced stress for both patients and veterinary staff.

This summary was distilled by AI and may occasionally misinterpret data. Confirm critical details with the primary literature before clinical application.